日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer.

NNMT 通过在非小细胞肺癌中形成 EGR1 和乳酸介导的双重正反馈环路来促进获得性 EGFR-TKI 耐药性

Dai Jiali, Lu Xiyi, Zhang Chang, Qu Tianyu, Li Wei, Su Jun, Guo Renhua, Yin Dandan, Wu Pingping, Han Liang, Zhang Erbao

Differential expression and analysis of extrachromosomal circular DNAs as serum biomarkers in pulmonary arterial hypertension

染色体外环状DNA作为肺动脉高压血清生物标志物的差异表达及分析

Zhang, Chun; Du, Qiang; Zhou, Xiao; Qu, Tianyu; Liu, Yingying; Ma, Kai; Shen, Ziling; Wang, Qun; Zhang, Zaikui; Zhang, Ruifeng

Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR-TKIs in advanced non-small cell lung cancer: A systematic review and network meta-analysis

抗血管生成药物或化疗联合EGFR-TKI治疗晚期非小细胞肺癌的疗效和安全性:系统评价和网络荟萃分析

Dai, Jiali; Liu, Xinyin; Li, Jun; Qu, Tianyu; Cui, Yanan; Jin, Shidai; Zhang, Erbao; Guo, Renhua

Characterization of VvmiR166s-Target Modules and Their Interaction Pathways in Modulation of Gibberellic-Acid-Induced Grape Seedless Berries

VvmiR166s靶模块及其在赤霉素诱导的葡萄无籽浆果调控中的相互作用通路特征分析

Yunhe Bai,Zhuangwei Wang,Linjia Luo,Xuxian Xuan,Wei Tang,Ziyang Qu,Tianyu Dong,Ziyang Qi,Mucheng Yu,Weimin Wu,Jinggui Fang,Chen Wang

Efficacy and acquired resistance of EGFR-TKI combined with chemotherapy as first-line treatment for Chinese patients with advanced non-small cell lung cancer in a real-world setting

在真实世界环境中,EGFR-TKI联合化疗一线治疗中国晚期非小细胞肺癌患者的疗效及获得性耐药情况

Wang, Qianqian; Gao, Wen; Gao, Fangyan; Jin, Shidai; Qu, Tianyu; Lin, Fan; Zhang, Chen; Zhang, Jingya; Zhang, Zhihong; Chen, Liang; Guo, Renhua